Cellectar Biosciences Inc ‘s stock market performance has been somewhat erratic.
52-week price history of CLRB Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Cellectar Biosciences Inc’s current trading price is -90.74% away from its 52-week high, while its distance from the 52-week low is 30.27%. The stock’s price range during the 52-week period has remained between $0.22 and $3.15. In the Healthcare sector, the company’s shares saw a trading volume of around 3.84 million for the day, which was evidently lower than the average daily volume of 12.02 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Cellectar Biosciences Inc (CLRB) has experienced a quarterly decline of -23.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 15.86M and boasts a workforce of 11 employees.
Making Sense of Trading Volume and Moving Average Data
Examining CLRB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CLRB stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.04.
CLRB Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -89.94%. However, over the past six months, we’ve seen a weaker performance of 13.23%. The price of CLRB fallen by 10.53% over the last 30 days. And in the last five days, it has fallen by -33.23%.
